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Abstract
Background: Clinical prediction models often fail to generalize in the context of
clustered data, because most models fail to account for heterogeneity in outcome
values and covariate effects across clusters. Furthermore, standard approaches for
modeling clustered data, including generalized linear mixed-effects models, would
not be expected to provide accurate predictions in novel clusters, because such
predictions are typically based on the hypothetical mean cluster. We hypothesized
that dynamic mixed-effects models, which incorporate data from previous
predictions to refine the model for future predictions, would allow for cluster-specific
predictions in novel clusters as the model is updated over time, thus improving
overall model generalizability.
Results: We quantified the potential gains in prediction accuracy from using a
dynamic modeling strategy in a simulation study. Furthermore, because clinical
prediction models in the context of clustered data often involve outcomes that are
dependent on patient volume, we examined whether using dynamic mixed-effects
models would be robust to misspecification of the volume-outcome relationship. Our
results indicated that dynamic mixed-effects models led to substantial improvements in
prediction accuracy in clustered populations over a broad range of conditions, and
were uniformly superior to static models. In addition, dynamic mixed-effects models
were particularly robust to misspecification of the volume-outcome relationship and to
variation in the frequency of model updating. The extent of the improvement in
prediction accuracy that was observed with dynamic mixed-effects models depended
on the relative impact of fixed and random effects on the outcome as well as the
degree of misspecification of model fixed effects.
Conclusions: Dynamic mixed-effects models led to substantial improvements in
prediction model accuracy across a broad range of simulated conditions. Therefore,
dynamic mixed-effects models could be a useful alternative to standard static models
for improving the generalizability of clinical prediction models in the setting of
clustered data, and, thus, well worth the logistical challenges that may accompany their
implementation in practice.
Keywords: Dynamic modeling, Bayesian statistics, Mixed-effects models, Prediction,
Clustered data, Generalizability
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Background
Despite the widespread adoption of prediction models in clinical research and medical
practice, there are often major concerns about model generalizability across different
populations and clinical settings. For instance, the EuroSCORE model, which was de-
veloped in European populations to predict 30-day mortality in patients undergoing
cardiac surgery, failed to generalize to Australian surgical patients [1], and, even within
the European population, proved inaccurate over time, over-predicting risk in contem-
porary practice [2]. In another example, a clinical prediction rule for predicting deep
vein thrombosis performed well in the secondary referral patient population in which it
was developed, but failed to generalize to a primary care setting [3]. This problem is
likely even more widespread than what has been directly documented in the literature
because of the many clinical outcomes that are known to vary substantially across clin-
ical sites, including readmission after hospitalization for heart failure [4], mortality fol-
lowing surgery for colorectal cancer [5], false-positive results from mammographic
screening [6], graft failure after liver transplantation [7], and medication adherence
rates among diabetes patients [8]. However, despite the high prevalence of such prob-
lems, relatively little research has been done to develop general approaches for improv-
ing model performance in the context of clustered, heterogeneous populations.
Notably, established methods for reducing overfitting, such as Bayesian model aver-
aging [9], bootstrap aggregation or bagging [10], and cross-validation [11], would not
be expected to improve model generalizability in this context, because they are unable
to test the model on samples from a different empirical distribution than the derivation
dataset, which is generally composed of data from a small number of clusters within a
larger clustered population.
One standard approach to modeling clustered data is with generalized linear mixed-
effects models (GLMM), which use random effects to parameterize heterogeneity in ef-
fects across clusters and induce a within-cluster correlation structure [12]. Although
GLMMs are theoretically capable of producing cluster-specific predictions, they would
not be expected to improve overall model generalizability across a clustered population,
because predictions on novel clusters (i.e. those that are not included in the original
data sample) are still based on the hypothetical mean cluster [13]. As a result, any
improvement in prediction accuracy that results from using mixed-effects models is
generally because of shrinkage effects, rather than incorporating knowledge about
cluster-specific differences. This limitation may explain why GLMMs are not used
more frequently for clinical prediction models.
However, this limitation of standard GLMMs may be alleviated if they are estimated
in a dynamic fashion. Dynamic prediction models have been recently proposed as a
method to improve the calibration of prediction models over time. In dynamic predic-
tion modeling, predictions are made on individuals using the best available model at
that time. Then, as the outcome data from previous predictions become available, they
can be incorporated into the data sample and used to update or refine the model.
Model updating can be performed in an online fashion through the continual adjust-
ment of Bayesian priors or by re-estimating the model using all of the available data in
either a Bayesian or frequentist approach [2, 14]. This method has been successfully
demonstrated in empirical examples [2, 14]. However, to our knowledge, this approach
has not previously been extended to prediction models in the context of clustered data,
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for which it might be expected to improve model generalizability. In particular, if a dy-
namic modeling framework were applied to mixed-effects models, novel clusters would
be converted into existing clusters within the data sample over time, allowing for pre-
dictions that account for cluster-specific differences. Thus, with dynamic mixed-effects
models, model generalizability can be improved over time as the model is used and up-
dated over an increasing number of unique clusters. Furthermore, previous research
has not studied the impact of model misspecification or updating frequency on the ac-
curacy of dynamic prediction models. These latter questions, in particular, are not eas-
ily addressed analytically and require direct testing via simulation.
In addition, many important clinical outcomes in the setting of clustered data show a
relationship between the outcome and cluster size, which is often referred to in the
clinical literature as ‘volume.’ For instance, it is well established that mortality following
major surgery is inversely related to the volume of patients receiving a given surgery at
a particular hospital [15]. This relationship has held true for many different specific
areas of surgery, as well, including thoracic [16], oncologic [17], and endovascular
surgery [18]. Hospital volume is also an important predictor of mortality following
hospitalization for myocardial infarction [19], mortality following inpatient mechanical
ventilation [20], and mortality following hospitalization for severe sepsis [21], among
other outcomes. Because many specific cases of prediction models in the context of
clustered data would be expected to have this volume-outcome relationship, it is
important to determine the robustness of the dynamic mixed-effects model approach
to misspecification of this association. Furthermore, while many other cluster-specific
effects would be expected to be easily accommodated by random intercepts and slopes
in dynamic mixed-effects models, the effect of volume could theoretically behave differ-
ently because it is directly related to the probability of observing the data responsible
for the updating process. In other words, predictions at smaller clusters could become
biased because the predictions are too heavily shrunk toward the predictions at larger
clusters, which make up the preponderance of the data. As a result, the robustness of
the dynamic approach to misspecification of the volume-outcome relationship needs to
be specifically assessed.
In this paper, we sought to quantify the potential improvement in prediction accuracy
from dynamic mixed-effects models in the context of clustered data via a simulation
study. We also examined whether using dynamic mixed-effects models would be robust
to misspecification of the volume-outcome relationship, misspecification of model fixed
effects, and variable frequencies of model updating. The results of these simulations
demonstrate the general utility of dynamic mixed-effects models for producing more
generalizable clinical prediction models in the setting of clustered data, and provide
motivation for further research toward solving the logistical and analytical challenges
that may accompany this approach in practice.
Methods
Dynamic mixed-effects models
GLMMs account for clustering in the outcome by treating some model parameters as
random, rather than fixed, across the population. These models typically follow
the form:
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g E Y ijjXij; bi
   ¼ Xijβþ Zibi; ð1Þ
in which the link function g(∙) relates the average outcome Yij for individual j in cluster
i to the observed covariate design matrices Xij and Zi through a vector of fixed effects β
and a vector of random effects bi, respectively [12]. Random effects are typically mod-
eled parametrically as N 0;Gð Þ , where G is the variance-covariance matrix of the ran-
dom effects. Use of this parametric structure for the random effects is typically more
efficient than cluster-level fixed effects, making it especially useful in settings where
there are a large number of clusters.
Mixed-effects models can be estimated using either a frequentist or Bayesian ap-
proach. In the context of Bayesian linear mixed-effects (BLME) models, prior distribu-
tions for β and bi —as well as the variance of the residual error conditional on the
random effects, σ2 —are fully specified and used to estimate posterior distributions
based on available data. The parametric structure of the random effects is specified as
hyperpriors on the distribution of bi. Thus, using our previous notation, the posterior
distribution of model parameters can be estimated conditional on the observed data as:
p β; bi; σ
2jY ij
 
∝p Y ijjβ; bi; σ2
 




for which p(β, bi, σ
2) is the prior distribution of all model parameters and p(Yij|β, bi, σ
2)
is the likelihood of the observed data given the model. Depending on the specific appli-
cation and the availability of prior information, prior distributions can be specified as
informative or non-informative. Use of non-informative priors is reflective of a typical
scenario for the initial development of a prediction model, when most researchers
would want to “let the data speak for themselves.”
We refer to the above models as ‘static’ models, because once they are estimated in
the derivation dataset, which we call the ‘training sample,’ the resulting model is used
to make out-of-sample predictions on the remainder of the population, which we call
the ‘testing sample,’ without any further refinement or adjustment. By contrast, dynamic
models are designed to capture data from out-of-sample predictions to update the
model for future predictions. Thus, the number of observations in the training sample
grows over time t, such that:
Xm tð Þ
i¼1 Ni tð Þ≤
Xm tþΔtð Þ
i¼1 Ni t þ Δtð Þ; ð3Þ
for which Ni(t) is the number of patients in the training sample for cluster i at time t,
and m(t) is the number of clusters in the training sample at time t. Also implied here
is that the number of clusters in the training sample is growing over time, or m(t) ≤
m(t +Δt). Static models are therefore a subset of dynamic models for which Ni(t) =
Ni(t +Δt) and m(t) =m(t + Δt) for all t. Furthermore, the quantity of data over time is
really the only difference between the two types of models, and, at any time t, the
dynamic model is equivalent to the static model that would have been produced if the
original training sample were the same as the training sample at time t. Note that the
model priors are not changing over time in our approach; however, accounting for
previous data in dynamic priors could be an alternative approach to implementing a
dynamic prediction model [14].
Combining a dynamic modeling approach with generalized mixed-effects models
would therefore be expected to allow a single prediction model to calibrate to local
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conditions, by incorporating novel clusters into the data sample used for model estima-
tion over time. In essence, many predictions that would have been made based on the
hypothetical mean cluster (bi = 0) with static models can be made using cluster-specific
random effects with dynamic models, and the extent of the improvement in prediction
accuracy from dynamic prediction models should depend on how quickly these cluster-
specific random effects can be estimated. Additionally, as with any mixed-effects model,
predictions at individual clusters are able to borrow strength from data at other clusters
to avoid the overfitting that might occur if separate models were fit at each cluster.
Simulation study
In our simulation, we aimed to develop and assess the accuracy of a model to predict a
hypothetical clinical outcome for individual patients, who are clustered within clinics.
The outcome Yij —which represented a hypothetical normally distributed, continuous
clinical outcome for patient j at clinic i—was dependent on X1ij, a known patient-level
predictor; X2ij, an unknown patient-level predictor; and Ni, the size of the clinic. Note
that X1ij and X2ij can also be interpreted as linear combinations of important predictors,
rather than just a single predictor. Clustering of the outcome was induced by a clinic-
level random intercept b0i and random slopes b1i and b2i. From 500 total clinics in the
population, 20 were randomly selected as the training sample. Using the training sam-
ple, we fit both dynamic and static versions of models with fixed effects only, as well as
those with random intercepts and random slopes. These models were then assessed in
the remaining clinics in the population, which constituted the testing sample. For each
combination of parameter values, the simulation was run 1,000 times to estimate the
degree of variability in the results. All simulations were performed using R 3.1.1 [22].
Data-generating process
For all simulations, we first generated a population of 500 clinics, each with Ni patients,
with:
Ni ∼ ⌈ exp N μN ; σ2N
  
⌉ ð4Þ
The log-normal distribution ensured that there were a large number of smaller
clinics, with a small number of very large clinics. The value for μN, for which exp (μN)
was equivalent to the median clinic size, was fixed at ln(65), while the value for σN was
fixed at ln(2), in order to ensure a range of clinic sizes of approximately 10 to 500
patients. Note that Ni refers to the number of patients at a clinic for whom predictions
will be made; patients at a given clinic who are not candidates for prediction do not
matter for purposes of this simulation.
Next, clinic-level random intercepts and slopes were generated from a multivariate
normal distribution:
b0i; ; b1i; ; b2if g ∼ N 0;Tð Þ; ð5Þ
for which b0i was the random intercept, b1i was the random slope for X1ij, b2i was the
random slope for X2ij, and the variance-covariance matrix was:









The correlation between the random intercept and random slopes, ρ, was fixed at a
moderate value of 0.3, which was felt to be similar to what might be observed in prac-
tice. However, sensitivity analyses demonstrated that the results were insensitive to in-
creases or decreases in the value of the correlation (data not shown). Additionally, we
determined that having the correlation between the random slopes differ from the cor-
relation between the random intercept and random slopes did not have a substantial
impact on the results (data not shown), so the same value for all correlations was used
to improve model simplicity.
After clinic-level random effects were generated, patient-level variables were gener-
ated. First, X1ij and X2ij were generated as N 0; 1ð Þ variables. The variance for these var-
iables was fixed at 1 for all parameter combinations to provide a reference point for
easier interpretation of the values of other parameters. We varied τ0
2 and τ1
2 to deter-
mine the impact of different relative strengths of clinic-level heterogeneities, compared
to patient-level factors.
The outcome Yij was then generated as:
Y ij ¼ b0i þ β1 þ b1ið ÞX1ij þ β2 þ b2ið ÞX2ij þ γf Nið Þ þ ij; ð7Þ
for which ij were independent errors distributed as N 0; σ2Þ








b0i þ ðβ1 þ b1iÞX1ij þ ðβ2 þ b2iÞX2ij þ γf ðNiÞ

; ð8Þ
with a value of α = σ2 /σY
2 = 0.2 chosen so that the variance of the residual error terms
was equal to 20 % of the total variance in Yij, denoted by σY
2. This value was thought to
be reflective of a typical high-quality clinical prediction model developed by rigorous
methods, where the majority of the variance is explained by the model. The value of α
was varied in sensitivity analyses to ensure that the results of the simulation were not
dependent on the value of this parameter. Clinic size was associated with the outcome
through the function f(∙), with:
f Nið Þ ¼ Ω ln Nið Þ−mean ln Nið Þð Þð Þ; ð9Þ
for which Ω was a scaling factor such that f Nið Þ e N 0; 1ð Þ. The value for β1 was fixed
at one across all simulations, so that β2 and γ gain the interpretation of the impact of
X2ij and clinic size on the outcome, respectively, relative to the impact of X1ij. Note that
the overall intercept across all clinics, β0, was defined as equal to 0 and is thus not
included in Equation 7.
Parameter values
The main parameters that were varied for our simulation were τ0
2 and τ1
2, which con-
trolled the relative impact of patient-level factors and clinic-level heterogeneities on the
outcome. Three values of each parameter were examined—0.5, 1, and 2 for τ0
2, and 0,
0.25, and 0.5 for τ1
2 —for a total of 9 main parameter combinations. The values of these
parameters can be interpreted relative to the size of the variance in X1ij, which was
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fixed at 1. Additionally, β2 and γ were fixed at zero for these main parameter combina-
tions, so that the effects of unknown patient-level factors and clinic size on the results
could be examined in isolation. When β2 was equal to zero, τ2
2 was also set equal to
zero, so that there was no effect of X2ij on Yij; when β2 was not equal to zero, τ2
2 was
set to be equal to τ1
2. We considered τ0
2 = 1, τ1
2 = 0.25, β2 = 0, and γ = 0 to be the ‘base’
parameter combination, and sensitivity analyses for individual parameters were based
on this combination of parameter values. For reference, in the base parameter combin-
ation, τ0/σ ≈ 4/3 and τ1/σ ≈ 2/3.









for both parameters. These values were selected for
greater interpretability, as the relative contribution of X2ij and f(Ni) to the total variance in
Yij was proportional to β2





contributed twice as much to the variance in Yij as did X1ij. This set of parameter values
likely covers the full range of what could reasonably be expected in practice, assuming
that prediction models would still be developed using rigorous methods and high quality
data. However, more extreme values of β2 were also examined in sensitivity analyses. For
this set of parameter combinations, τ0
2 and τ1
2 were fixed at their base values.
Finally, we assessed the impact of varying update intervals in an attempt to reflect longer
time lags between predictions and the occurrence of the outcome, which might take place
in certain clinical scenarios, such as those with survival-type outcomes. We examined values
of 250, 500, 1,000, and 5,000 for θ —where θ is the number of predictions made between
cycles of updating for dynamic models, and 0.8 * θ is the expected number of new subjects
incorporated into the dynamic models at each iteration, as described below. We used
θ = 500 as its base value for all previously described parameter combinations.
Prediction models
We randomly selected 20 clinics—stratified by clinic-size quintile, Ni
* —for the training
sample, mimicking a large multi-center cohort that might be used to develop a clinical
prediction model in practice. We selected 6 clinics from each of the bottom two
quintiles, three clinics from each of the next two quintiles, and two clinics from the
upper quintile. We then developed three prediction models in the training sample:
1). A linear model, β1X1ij;
2). A BLME model with a random intercept, b0i + β1X1ij;
3). A second BLME model with a random intercept and slope, b0i + (β1 + b1i)X1ij.
BLME models were fit using restricted maximum likelihood, with non-informative flat
priors for the fixed effects and a non-informative prior for the random effects covariance
matrix based on the Wishart distribution. Estimation of BLME models was accomplished
using the blme extension package in R [23]. Additionally, for simulations when γ ≠ 0, we
also constructed versions of the above models that included Ni
* as a categorical fixed effect,
because it was felt that Ni
* would be more likely to be observable than f(Ni) in practice.
All three models were assessed in the testing sample both as dynamic and static
models. Note that the static linear model is meant to reflect the typical prediction
model that would be developed and used in practice. Dynamic modeling was achieved
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by making predictions on θ patients, incorporating outcome data on those individuals
back into the training sample, re-estimating the models, and then making predictions
on the next θ patients. This algorithm was repeated until predictions had been made
on all patients in the testing sample. For BLME models, this was equivalent to adding
new data, and did not affect the model priors. The order of predictions was random
across the entire testing sample, and each individual had an 80 % chance to have their
outcome data incorporated into the training sample for future model updates. We
chose 80 % because it realistically allows for missing outcome data; this is reflective of
missing outcome data that might occur when utilizing a dynamic prediction modeling
scheme in practice, where patients might be lost to follow-up before their outcomes are
observed. Note that in this set-up, the expected number of new subjects incorporated
into the dynamic model at each iteration is 80 % of the value of θ.
Assessment of model calibration
Accuracy of prediction models was based on model calibration, which was assessed as
mean absolute error (MAE) [24]. MAE was calculated as:






for which n was the total number of individuals in the training sample. To improve the
interpretability of the results, we constructed a metric, the ‘relative improvement’ (RI)




where ϕ0 refers to the MAE for the intercept-only model, as fit in the training sample,
and ϕ1 refers to the MAE for the ‘true’ model, which was considered to be the model
in Equation 7, minus the residual error term, ij. Thus, the RI will typically range from
0 to 1 and can be interpreted as the improvement of the current model over the
intercept-only model, relative to the improvement that would have been seen with the
true model. Negative values for RI indicate that the given model is worse than predict-
ing the average value in all individuals. Thus, the RI for a given model is analogous to
the relative utility metric proposed by Baker [25], except in the context of model
calibration and without the decision-theoretic weighting scheme. Furthermore, because
the MAE of all of the models contain the same residual error, ij, this term is factored
out of the RI, giving the metric the advantageous feature of being relatively insensitive
to changes in the magnitude of σ2 .
Results
Population characteristics
There were 41,576 (SD 1,465) patients in the total simulated population, on aver-
age, with 1,276 (SD 118) patients in the training sample. Within a given simula-
tion, clinics ranged in size from 9 to 549 patients, on average. The median clinic
had 66 patients, and 67 % of patients were in clinics in the top two quintiles of
clinic size. Clinics in the smallest quintile of clinic size had between 9 and 36
patients, on average, while those in the largest quintile had 117 or more patients,
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on average. A visualization of the effect of varying τ0
2 and τ1
2 on clinic-level cluster-
ing can be seen in Additional file 1: Figure S1.
Main parameter results
As can be seen in Table 1, the prediction models were very accurate in the training sam-
ple, with the RI in the training sample ranging from 24 to 101 %, depending on the model
and parameter combination. In particular, RI in the training sample was uniformly 101 %
for the BLME model with both a random intercept and random slope, indicating overfit-
ting. Although the addition of random effects led to dramatic improvements in the model
accuracy in the training sample, they led to virtually no improvement in the accuracy of
predictions as assessed in the testing sample, with a mean RI of 33 to 34 % for all static
models for the base parameter combination. In contrast, use of dynamic modeling led to
dramatic improvements in RI for both BLME models, across all main parameter combina-
tions tested, with RI values generally in excess of 70 % (Fig. 1).
As can be seen in Fig. 2, gains in prediction accuracy from dynamic mixed-effects
models were seen across all clinic-size quintiles, although the greatest improvement
was seen in the largest clinics. This pattern likely reflects the fact that improvements
from dynamic modeling were seen relatively rapidly, with approximately 80 % of the
total gains in predictive performance for the dynamic BLME models occurring on aver-
age after about 7 and 9 predictions at a given clinic for the model with a random inter-
cept and the model with both a random intercept and random slope, respectively
(Fig. 3). Because there were 480 clinics in the testing sample and the model was up-
dated after every 500 predictions, model updates occurred after almost every predic-
tion, especially at smaller clinics. The rate of improvement in predictive accuracy was
somewhat sensitive to changes in σ2 , however, with 80 % of the total gains in predict-
ive performance for the dynamic BLME model with both a random intercept and slope
occurring after about 17 predictions at a given clinic, on average, when the residual
error was equal to 50 % of the overall variance in Yij (Additional file 1: Figure S2).
Noticeable decreases in RI values for dynamic BLME models were seen only at very
extreme values for σ2 , such as when the residual error was equal to 80 % of the total
variance in Yij (Additional file 1: Figure S3). However, even at this extreme and likely
Table 1 Mean RI for static models in training sample for all main parameter combinations
τ12 Model τ02 = 0.5 τ02 = 1 τ02 = 2
β1X1 0.424 (0.121) 0.337 (0.114) 0.244 (0.101)
0.5 b0i + β1X1 0.714 (0.099) 0.767 (0.084) 0.826 (0.068)
b0i + (β1 + b1i)X1 1.014 (0.006) 1.014 (0.005) 1.014 (0.006)
β1X1 0.496 (0.105) 0.382 (0.107) 0.267 (0.097)
0.25 b0i + β1X1 0.827 (0.067) 0.863 (0.056) 0.902 (0.044)
b0i + (β1 + b1i)X1 1.014 (0.005) 1.013 (0.005) 1.013 (0.005)
β1X1 0.604 (0.098) 0.445 (0.106) 0.297 (0.097)
0 b0i + β1X1 1.007 (0.003) 1.007 (0.003) 1.007 (0.004)
b0i + (β1 + b1i)X1 1.013 (0.004) 1.013 (0.005) 1.013 (0.005)
Results presented as mean (SD) for 1,000 simulations
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unrealistic parameter value, dynamic BLME models outperformed static models, with
RI values for the former in excess of 70 %.
Effect of model misspecification
When there was an unknown patient-level factor impacting the outcome (i.e. β2 ≠ 0),
dynamic prediction modeling was less effective (Fig. 4). However, dynamic models still were
more accurate than static models for all values of β2. Larger values of β2 were also associated
with a slower rate of improvement in predictive accuracy, with 80 % of the total gains in
predictive performance for the dynamic BLME model with both a random intercept and





Figure S4). Nevertheless, overall gains in prediction accuracy were still observed for clinics
in the smallest quintile of clinic size, even at larger values of β2 (data not shown).
Having the outcome be dependent on clinic size (i.e. γ ≠ 0) led to worse performance
of static BLME models, with these models performing worse than intercept-only
models at large values of γ (Fig. 5). However, dynamic BLME models showed no
Fig. 1 Relative improvement in MAE for both dynamic and static models across all main parameter
combinations. Plots show the density of values for relative improvement in MAE across 1,000 simulations,
with horizontal bars representing the mean value. All other parameters are fixed at their base values. The
center figure represents the base parameter combination
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decrease in prediction accuracy with non-zero values of γ. Including Ni
* as a categorical
fixed effect in models led to marked improvement in static BLME models, as well as
slight improvement in dynamic BLME models, on average (Fig. 6).
Effect of varying the update interval
Results were fairly insensitive to changes in θ, the update interval. Even when θ = 5,
000, or about 12.5 % of the testing sample, prediction accuracy in dynamic BLME
models was not substantially decreased (Additional file 1: Figure S5). Furthermore,
prediction accuracy was consistent across all quintiles of clinic size with varying values
of θ (Additional file 1: Figure S6). Finally, the rate of improvement in prediction accur-
acy showed a meaningful decrease only when θ = 5, 000, with about 80 % of total gains
in prediction accuracy occurring on average after about 19 and 20 predictions at a
given clinic for the model with a random intercept and the model with both a random
intercept and random slope, respectively, in this scenario (Fig. 3).
Computational time
Mean computational time for dynamic and static models under base parameter values
are shown in Fig. 7. Static models are run once using the training sample, which had
1,276 subjects on average. After an initial reduction in computational time due to the
improved efficiency from adding additional clusters, dynamic BLME models tended to
have approximately linear increases in computational time with increasing number of
iterations, as about 400 subjects were incorporated into the model for each round of
subsequent updates.
Discussion
In this simulation study, we sought to quantify the potential effect of dynamic prediction
modeling on prediction model accuracy in the context of clustered data. Dynamic BLME
models were uniformly more accurate than static models across all parameter combina-
tions examined. Moreover, they were more accurate than static models in the context of
model misspecification, and were particularly robust to misspecification of the volume-
Fig. 2 Relative improvement in MAE by clinic-size quintile. Plots show the density of values for relative
improvement in MAE across 1,000 simulations, with horizontal bars representing the mean value. These
results are for the base parameter combination
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outcome relationship. As a result, it seems quite likely that the use of dynamic mixed-
effects models would lead to substantial improvement in the generalizability of clinical
prediction models in the context of clustered data. However, the extent of the gains in
prediction accuracy from dynamic modeling was sensitive to the degree of misspecifica-
tion of model fixed effects, indicating that, as with all prediction modeling, the best results
will be seen when models are developed rigorously using high-quality data.
Impact of dynamic prediction modeling
As expected, dynamic prediction modeling did not yield substantial improvement
in prediction accuracy with the linear model, performing similarly to all static
Fig. 3 Effect of the update interval on the rate of improvement in prediction accuracy at a given clinic.
This plot shows the mean relative improvement in MAE for prediction j at clinic i, across 1,000 simulations
for different values of the update interval, θ. Vertical dashed and dotted lines indicate the point at which
80 % of the total gains in prediction accuracy have been achieved for the dynamic BLME model with a
random intercept and the dynamic BLME model with a random intercept and random slope, respectively.
Note that the base value of θ is 500, and all other parameters are fixed at their base values
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models, because the model did not have the flexibility to account for clinic-level
variability. By contrast, dynamic BLME models were able to account for this vari-
ation, leading to improvement in predictive accuracy. The dynamic BLME model
with a random intercept showed improved prediction accuracy with increasing
values of τ0
2; however, its performance deteriorated with higher values of τ1
2. This
deterioration in accuracy with larger random slopes is not surprising, because this
model had no way to account for the random slopes that were present in the data.
Even so, the model was able to use its random intercept to account for a large
enough amount of inter-clinic variability to provide substantial and uniform im-
provement over static models and the dynamic linear model.
The dynamic BLME model with both a random intercept and random slope was nearly
as accurate as the true model across all main parameter combinations, with a mean RI
ranging from 94 to 96 %. This was because the data-generating model (Equation 7) was
also based on a random intercept and random slope for most parameter combinations,
Fig. 4 Effect of unknown patient-level predictor on model prediction accuracy. Plots show the density of
values for relative improvement in MAE across 1,000 simulations, with horizontal bars representing the
mean value, for different values of β2, which controls the size of the effect of the unknown patient-level
predictor, X2ij, to the outcome, Yij. Note that the relative contribution of X2ij to the total variance in Yij,
compared to X1ij, is equal to β22. All other parameters are fixed at their base values
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and updating occurred fast enough that predictions on most individuals in the testing
sample were made with a fully calibrated model. Indeed, about 80 % of the gains in pre-
diction accuracy were seen by about the 9th patient at a given clinic, although this rate of
improvement was somewhat sensitive to the magnitude of the residual error. However,
even smaller clinics were still able to see benefits from dynamic prediction modeling
across all of the examined parameter combinations, and the majority of predictions
at large clinics were made with an accurate estimate of clinic-specific random ef-
fects. This rapid improvement in prediction accuracy was largely sustained even
with higher values of θ, so overall prediction accuracy in the testing sample was
preserved even when models were updated less frequently and using more new
data per update. It should also be noted that this high level of prediction accuracy
was sustained even when there was no random slope in the data-generating
process (τ1
2 = 0). Thus, there was not really much downside to having an unneces-
sary random slope in the dynamic BLME model, while having only a random
Fig. 5 Effect of an association between clinic size and the outcome on model prediction accuracy. Plots
show the density of values for relative improvement in MAE across 1,000 simulations, with horizontal bars
representing the mean value, for different values of γ, which controls the size of the effect of scaled clinic
size, f(Ni), on the outcome, Yij. Note that the relative contribution of f(Ni) to the total variance in Yij,
compared to X1ij, is equal to γ2. All other parameters are fixed at their base values
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intercept when the data-generating process included both a random intercept and
a random slope led to decreased prediction accuracy.
Additionally, the variance of RI values across simulations tended to be lower in
dynamic than static models. The variance in prediction accuracy decreased with each
additional random effect in the model, as well. This speaks to another important
feature of dynamic mixed-effects models that can be identified based on our simulation
results, which is the ability to overcome sampling bias in the training sample to pro-
duce models that perform more consistently in the overall population. By contrast, in
static models, the prediction accuracy was largely dependent on whether the clinics
that comprised the training sample happened to be representative of the overall popu-
lation. In simulations where estimates of β0 and β1 were very different from their true
values due to random sampling, prediction accuracy for static models in the testing
sample tended to be worse (Additional file 1: Figures S7–S9). However, dynamic
models were able to overcome initial sampling bias by rapidly improving model calibra-
tion over time.
Fig. 6 Effect of including clinic-size quintile as a fixed effect on prediction model accuracy. Plots show the
density of values for relative improvement in MAE across 1,000 simulations, with horizontal bars representing
the mean value, for different values of γ, which controls the size of the effect of scaled clinic size, f(Ni), on the
outcome, Yij. All models include clinic-size quintile, Ni
*, as a categorical fixed effect, because Ni
* was defined to
be observed while Ni was defined to be unobserved. Note that the relative contribution of f(Ni) to the total
variance in Yij, compared to X1ij, is equal to γ2. All other parameters are fixed at their base values
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Impact of model misspecification
Model misspecification is a common problem in clinical prediction models, as important
clinical predictors are often unknown, difficult to measure, or nonlinearly related to the
outcome of interest. We simulated model misspecification by including an unknown
patient-level factor, X2ij, in the data-generating process. When this factor was allowed to
influence the outcome (β2 ≠ 0), dynamic BLME models had a decrease in prediction
accuracy; however, they still performed better than static models for all values of β2. More
extreme values of β2 showed a similar pattern (Additional file 1: Figure S10). In short, for
dynamic prediction models, it is still important to be rigorous when selecting covariates
and determining their specification [26], because models that are closest to being correctly
specified will still perform the best. However, the fact that dynamic mixed-effects models
were more accurate in the context of model misspecification suggests that their use may
be a useful strategy in the real world.
Cluster size or volume may be related to outcomes in a number of clinical scenarios,
such as hospital mortality rates for acute myocardial infarction or surgical mortality
rates [15, 19, 27]. While other cluster-level effects can be easily accommodated by ran-
dom intercepts and slopes, volume could theoretically behave differently because it is
directly related to the probability of observing the data in the first place. Larger values
of γ, and thus larger effects of volume, led to worse performance of static BLME
models, while dynamic BLME models showed no deterioration in performance. Import-
antly, static BLME models performed worse than static linear models when γ ≠ 0,
unless fixed effects for clinic-size quintile (Ni
*) were included in the model. To our
knowledge, this finding concerning prediction in novel clusters for static mixed-effects
models has not been previously reported. Upon further examination, in static BLME
Fig. 7 Computational time of static and dynamic models. The mean computational times in seconds for
the static models are shown by the open circles. From bottom to top, the circles represent the linear
model, the BLME model with a random intercept, and the BLME model with a random intercept and a
random slope. The mean computational times for the dynamic linear model, BLME model with a random
intercept, and BLME model with a random intercept and a random slope, are shown by the solid, dashed,
and dotted lines, respectively. All parameters are fixed at their base values
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models, the effect of sampling bias was actually amplified because differences due to
clinic size were incorporated into the model as random effects, with greater bias in the
estimated random effects covariance matrix leading to worse prediction accuracy
(Additional file 1: Figures S11–S12). However, in dynamic BLME models, these initial
biases rapidly diminished over time because the model was continually being calibrated
to the overall population, such that the majority of predictions were unaffected by the
initial biases. In essence, the volume-outcome relationship could be incorporated into
cluster-specific random intercepts over time, even though this was not actually the cor-
rect specification of the data structure. As a result, inclusion of Ni
* was required to im-
prove the accuracy of static BLME models, but not practically necessary in the case of
dynamic BLME models, at least for the cluster sizes that were included in the simula-
tion (i.e. Ni ≥ 10). These results suggest that dynamic mixed-effects models can be an
important tool for prediction in clinical scenarios with volume-outcome relationships,
as they do not necessarily require proper specification of this relationship to yield dra-
matic improvements in prediction accuracy.
We also conducted sensitivity analyses where both the known and unknown patient-
level factors, X1ij and X2ij, had a non-linear relationship with the outcome by adding
squared terms to the data-generating model (Additional file 1: Figures S13–S14). The
results of these sensitivity analyses were similar, in that the gains of prediction accuracy
from using dynamic BLME models were reduced in scenarios with greater degrees of
model misspecification, although for both static and dynamic models the magnitude of
the reduction in RI from misspecification of non-linear terms was somewhat larger
than seen from misspecification of linear terms. However, even in the case of misspeci-
fication of non-linear relationships, there was no scenario identified in which dynamic
BLME models were less accurate than static BLME models.
Interestingly, in cases of extreme model misspecification, there seemed to be a pat-
tern of the dynamic BLME model with both a random intercept and a random slope
having slightly worse prediction accuracy than the dynamic BLME model with only a
random intercept. This result may suggest that dynamic BLME models with more com-
plexity or greater degrees of freedom may perform slightly worse in situations of ex-
treme model misspecification, perhaps because these models are somewhat more likely
to suffer from overfitting of noise in the data. Thus, using more conservative dynamic
models may be prudent in situations where extreme misspecification is more likely.
However, the large gains in accuracy from model updating always exceeded the minor
effects of overfitting, making even complex dynamic models superior to static models.
Impact of the update interval
Previous research on dynamic prediction models have not examined whether the
frequency with which the model is updated would impact the expected gains in predic-
tion accuracy. In many clinical scenarios, updating frequency could be limited by com-
putational constraints or logistical challenges related to data collection, as well as by
time lags between when predictions are made and when the outcomes actually occur.
Fortunately, our results show that gains in prediction accuracy seen with dynamic
mixed-effects models are robust to less frequent updating intervals, with only minor re-
ductions in prediction accuracy at very high values of θ. As a result, dynamic mixed-
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effects models should be feasible in situations where real world constraints limit the
frequency of model updating.
Challenges to using dynamic prediction modeling in practice
Implementation of dynamic mixed-effects models in practice will likely involve many
logistical and analytical challenges. Ideally, prediction models would be integrated into
electronic health record systems, so they will be able to automatically extract covariate
data to make an initial prediction, and then automatically extract outcome data to use
for model updating. Furthermore, in order to accommodate heterogeneities across sites,
the electronic health record will need to either be standardized across all of the sites,
or be compatible enough to allow for communication of data. Additionally, the data
storage and security requirements for large amounts of data across multiple sites will
likely be quite complex. Certain analytic strategies—such as Bayesian dynamic regres-
sion, where posterior distributions are estimated from dynamic priors in a fully online
fashion [14]—could greatly reduce the data storage requirements, and, accordingly, the
data security concerns. These analytic strategies may also help reduce the computa-
tional burden of running dynamic models on increasingly large amounts of data, as
well. However, more simulation work is needed to determine the trade-offs in predic-
tion accuracy that might accompany this estimation approach under certain scenarios.
Finally, there will need to be a concerted effort to communicate the effectiveness of this
approach to the clinical community in order to foster the necessary level of trust to
overcome initial financial and logistical hurdles.
The analytic challenges involved with dynamic prediction modeling are also likely to be
quite complex. Missing data, both for covariates and outcomes, will be an important issue
to resolve, because standard methods, such as multiple imputation [28, 29], may be
difficult to implement in the context of a dynamic system. As a result, efforts to jointly
model the updating process along with the prediction model itself, analogous to methods
for jointly modeling longitudinal and competing risks data [30], may be required. Alterna-
tively, use of missing indicators may be of greater use than with standard models [31],
because these parameters would be allowed to calibrate to the population over time.
However, further studies are needed to answer these questions empirically.
Study limitations
Although our simulation was based on a hypothetical predictor and outcome variable,
we tried wherever possible to mimic situations that might occur when developing and
utilizing a typical clinical prediction model. For instance, we used a log-normal distri-
bution for clinic size, so that there would be a larger number of small clinics than large
clinics, and we generated the training sample to be similar in size and composition to a
large multi-center cohort study. We also excluded some patients from contributing
data to dynamic models, to reflect the loss to follow-up that might occur in clinical
practice. Finally, we examined scenarios where the model was not correctly specified,
which are likely to occur in real-world applications.
Despite these efforts, there were still a number of limitations to our model. For in-
stance, we did not examine scenarios where heterogeneities across clinics were not nor-
mally distributed. It is possible that standard BLME models might not perform as well
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in this scenario, leading to a model that was less calibrated to local conditions, even
after updating. However, research studying the impact of misspecified parameterization
of random effects on prediction accuracy suggests that the standard multivariate nor-
mal assumptions should be reasonably robust [32]. Additionally, we assumed in our
simulation that outcome data that were not available for updating were missing com-
pletely at random, which may not hold in practice. Future studies are needed to deter-
mine whether the prediction accuracy of dynamic prediction models will be worsened
in scenarios where the probability of obtaining outcome data for updating is dependent
on model covariates or, especially, the outcome.
Furthermore, we only tested the simple case of a normally distributed, linear out-
come. It is possible that the relative rate of improvement in model accuracy for dy-
namic models could be different for other types of data, such as binary or count data,
due to differences in the relative efficiency of the models involved. Because GLMMs
are asymptotically consistent regardless of the link function or error distribution used,
we would expect that dynamic mixed-effects models would also show overall improve-
ment compared to static models regardless of the type of data under consideration,
since the process of model updating allows for the accumulation of additional data.
More research, however, will be needed to formally test the relative performance of
dynamic mixed-effects modeling under various conditions for other distributions in the
exponential family, or even non-exponential data, such as survival data.
We attempted to cover a reasonable range of parameter values in our analysis, in-
cluding some parameter values that reflect more extreme cases of model misspecifica-
tion; however, it is possible that our results will not extrapolate to values outside of the
tested ranges. For instance, cluster size was rarely less than ten individuals for our
simulation; however, there is empirical evidence to suggest that mixed-effects models
may perform poorly on such very small clusters when there is a strong volume-
outcome relationship [19]. As a result, we would encourage caution when utilizing
dynamic mixed-effects models in clusters with less than ten individuals when there is a
known strong volume-outcome relationship. Additionally, to reduce computational
burdens, we focused on a simplistic model: a single continuous predictor and a con-
tinuous outcome. Clearly, clinical prediction models in the real world will have multiple
covariates, and many will have more complex outcomes. The exact gains in prediction
accuracy from dynamic prediction modeling will likely vary depending on the particular
structure of the data in question, with more complex models likely requiring more time
and more data to become fully calibrated. Future research is needed to better
characterize the performance of dynamic mixed-effects models as a function of model
complexity. Finally, dynamic prediction modeling in practice will have to deal with a
lag between when predictions are made and when outcomes are observed. For instance,
in models predicting five-year survival in cancer, it could be years before outcomes are
obtained to be included for model updating. It is possible that long lag periods relative
to the frequency of updating will decrease the rate at which prediction accuracy im-
proves. As a result, dynamic mixed-effects models may be less useful for outcomes with
long lag times, especially at smaller clinics or in rapidly changing populations. We
attempted to assess the sensitivity of our results to long lag times by varying the update
interval, θ, and large improvements in prediction accuracy with dynamic BLME models
were still seen even at the highest values of θ. Even with these positive results, though,
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the exact effect of time lags on the performance of dynamic prediction models will
need to be formally addressed in future research.
Conclusions
In conclusion, use of dynamic mixed-effects models led to more accurate predictions in
the overall population compared with static prediction models. The extent of the im-
provement in prediction accuracy that was observed depended on the relative impact
of fixed and random effects on the outcome as well as the degree of model misspecifi-
cation. Nonetheless, dynamic mixed-effects models were uniformly superior to static
models as well as dynamic models with only fixed effects. Gains in prediction accuracy
tended to occur rapidly, leading to improvements at small clinics as well as large
clinics. Dynamic mixed-effects models were also particularly robust to misspecification
of the volume-outcome relationship as well as to variation in the update interval. While
there are many logistical and analytical questions to resolve, dynamic mixed-effects
models appear to be a useful approach for improving the accuracy and generalizability
of clinical prediction models in the context of clustered data.
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